Insulet’s (PODD) Outperform Rating Reiterated at Raymond James
Insulet (NASDAQ:PODD – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at Raymond ...
Insulet (NASDAQ:PODD) Shares Gap Down – What’s Next?
Insulet Co. (NASDAQ:PODD – Get Free Report)’s share price gapped down before the market opened on Friday . The stock had previously closed at $288.29, but opened at $276.35. Insulet shares last traded ...
Zacks.com on MSN1d
PODD Stock Falls Despite Q4 Earnings and Revenue Beat, Margins Rise
Insulet Corporation PODD reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.15, down significantly 17.8% ...
Hosted on MSN2d
Insulet’s (NASDAQ:PODD) Q4: Beats On Revenue, Quarterly Revenue Guidance Slightly Exceeds Expectations
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2024 results , with sales up 17.2% year on year to ...
Zacks.com on MSN2d
Insulet (PODD) Q4 Earnings and Revenues Top Estimates
Insulet (PODD) delivered earnings and revenue surprises of 9.52% and 2.73%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Nasdaq1mon
GEHC or PODD: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Insulet (PODD). But which of these two stocks is more attractive to value investors?
Yahoo Finance9d
Insulet Corporation (PODD)
Beyond analysts' top -and-bottom-line estimates for Insulet (PODD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...
Insulet: Q4 Earnings Snapshot
Insulet Corp. (PODD) on Thursday reported fourth-quarter profit of $100.7 million. On a per-share basis, the Acton, Massachusetts-based company said it had ...